Hematology and Oncology Associates of NEPA

Dunmore, Pennsylvania 18512

We've found

1 trials

at this facility

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Dunmore, PA

Use our guide to learn which trials are right for you!